IBDEI1E7 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22526,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22526,1,3,0)
;;=3^Exfoliation d/t Erythematous Cond w/ 60-69% Body Surface
;;^UTILITY(U,$J,358.3,22526,1,4,0)
;;=4^L49.6
;;^UTILITY(U,$J,358.3,22526,2)
;;=^5009196
;;^UTILITY(U,$J,358.3,22527,0)
;;=L49.7^^76^970^23
;;^UTILITY(U,$J,358.3,22527,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22527,1,3,0)
;;=3^Exfoliation d/t Erythematous Cond w/ 70-79% Body Surface
;;^UTILITY(U,$J,358.3,22527,1,4,0)
;;=4^L49.7
;;^UTILITY(U,$J,358.3,22527,2)
;;=^5009197
;;^UTILITY(U,$J,358.3,22528,0)
;;=L49.8^^76^970^24
;;^UTILITY(U,$J,358.3,22528,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22528,1,3,0)
;;=3^Exfoliation d/t Erythematous Cond w/ 80-89% Body Surface
;;^UTILITY(U,$J,358.3,22528,1,4,0)
;;=4^L49.8
;;^UTILITY(U,$J,358.3,22528,2)
;;=^5009198
;;^UTILITY(U,$J,358.3,22529,0)
;;=L49.9^^76^970^27
;;^UTILITY(U,$J,358.3,22529,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22529,1,3,0)
;;=3^Exfoliation d/t Erythematous Cond w/ > 89% Body Surface
;;^UTILITY(U,$J,358.3,22529,1,4,0)
;;=4^L49.9
;;^UTILITY(U,$J,358.3,22529,2)
;;=^5009199
;;^UTILITY(U,$J,358.3,22530,0)
;;=Z65.5^^76^970^28
;;^UTILITY(U,$J,358.3,22530,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22530,1,3,0)
;;=3^Exposure to Disaster/War/Hostilities
;;^UTILITY(U,$J,358.3,22530,1,4,0)
;;=4^Z65.5
;;^UTILITY(U,$J,358.3,22530,2)
;;=^5063184
;;^UTILITY(U,$J,358.3,22531,0)
;;=Z77.22^^76^970^29
;;^UTILITY(U,$J,358.3,22531,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22531,1,3,0)
;;=3^Exposure to/Contact w/ Environmental Tobacco Smoke
;;^UTILITY(U,$J,358.3,22531,1,4,0)
;;=4^Z77.22
;;^UTILITY(U,$J,358.3,22531,2)
;;=^5063324
;;^UTILITY(U,$J,358.3,22532,0)
;;=L30.9^^76^970^5
;;^UTILITY(U,$J,358.3,22532,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22532,1,3,0)
;;=3^Eczema,Unspec
;;^UTILITY(U,$J,358.3,22532,1,4,0)
;;=4^L30.9
;;^UTILITY(U,$J,358.3,22532,2)
;;=^5009159
;;^UTILITY(U,$J,358.3,22533,0)
;;=L23.9^^76^970^2
;;^UTILITY(U,$J,358.3,22533,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22533,1,3,0)
;;=3^Eczema,Allergic Contact,Unspec
;;^UTILITY(U,$J,358.3,22533,1,4,0)
;;=4^L23.9
;;^UTILITY(U,$J,358.3,22533,2)
;;=^5009125
;;^UTILITY(U,$J,358.3,22534,0)
;;=L20.82^^76^970^3
;;^UTILITY(U,$J,358.3,22534,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22534,1,3,0)
;;=3^Eczema,Flexural
;;^UTILITY(U,$J,358.3,22534,1,4,0)
;;=4^L20.82
;;^UTILITY(U,$J,358.3,22534,2)
;;=^5009109
;;^UTILITY(U,$J,358.3,22535,0)
;;=L20.84^^76^970^4
;;^UTILITY(U,$J,358.3,22535,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22535,1,3,0)
;;=3^Eczema,Intrinsic
;;^UTILITY(U,$J,358.3,22535,1,4,0)
;;=4^L20.84
;;^UTILITY(U,$J,358.3,22535,2)
;;=^5009111
;;^UTILITY(U,$J,358.3,22536,0)
;;=L51.8^^76^970^11
;;^UTILITY(U,$J,358.3,22536,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22536,1,3,0)
;;=3^Erythema Multiforme,Other
;;^UTILITY(U,$J,358.3,22536,1,4,0)
;;=4^L51.8
;;^UTILITY(U,$J,358.3,22536,2)
;;=^336639
;;^UTILITY(U,$J,358.3,22537,0)
;;=R23.4^^76^970^15
;;^UTILITY(U,$J,358.3,22537,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22537,1,3,0)
;;=3^Eschar/Desquamination of Skin
;;^UTILITY(U,$J,358.3,22537,1,4,0)
;;=4^R23.4
;;^UTILITY(U,$J,358.3,22537,2)
;;=^5019296
;;^UTILITY(U,$J,358.3,22538,0)
;;=L49.9^^76^970^25
;;^UTILITY(U,$J,358.3,22538,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1E7 3760 printed Sep 23, 2025@19:43 Page 2
IBDEI1E7 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22526,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,22526,1,3,0)
+4 ;;=3^Exfoliation d/t Erythematous Cond w/ 60-69% Body Surface
+5 ;;^UTILITY(U,$J,358.3,22526,1,4,0)
+6 ;;=4^L49.6
+7 ;;^UTILITY(U,$J,358.3,22526,2)
+8 ;;=^5009196
+9 ;;^UTILITY(U,$J,358.3,22527,0)
+10 ;;=L49.7^^76^970^23
+11 ;;^UTILITY(U,$J,358.3,22527,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,22527,1,3,0)
+14 ;;=3^Exfoliation d/t Erythematous Cond w/ 70-79% Body Surface
+15 ;;^UTILITY(U,$J,358.3,22527,1,4,0)
+16 ;;=4^L49.7
+17 ;;^UTILITY(U,$J,358.3,22527,2)
+18 ;;=^5009197
+19 ;;^UTILITY(U,$J,358.3,22528,0)
+20 ;;=L49.8^^76^970^24
+21 ;;^UTILITY(U,$J,358.3,22528,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,22528,1,3,0)
+24 ;;=3^Exfoliation d/t Erythematous Cond w/ 80-89% Body Surface
+25 ;;^UTILITY(U,$J,358.3,22528,1,4,0)
+26 ;;=4^L49.8
+27 ;;^UTILITY(U,$J,358.3,22528,2)
+28 ;;=^5009198
+29 ;;^UTILITY(U,$J,358.3,22529,0)
+30 ;;=L49.9^^76^970^27
+31 ;;^UTILITY(U,$J,358.3,22529,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,22529,1,3,0)
+34 ;;=3^Exfoliation d/t Erythematous Cond w/ > 89% Body Surface
+35 ;;^UTILITY(U,$J,358.3,22529,1,4,0)
+36 ;;=4^L49.9
+37 ;;^UTILITY(U,$J,358.3,22529,2)
+38 ;;=^5009199
+39 ;;^UTILITY(U,$J,358.3,22530,0)
+40 ;;=Z65.5^^76^970^28
+41 ;;^UTILITY(U,$J,358.3,22530,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,22530,1,3,0)
+44 ;;=3^Exposure to Disaster/War/Hostilities
+45 ;;^UTILITY(U,$J,358.3,22530,1,4,0)
+46 ;;=4^Z65.5
+47 ;;^UTILITY(U,$J,358.3,22530,2)
+48 ;;=^5063184
+49 ;;^UTILITY(U,$J,358.3,22531,0)
+50 ;;=Z77.22^^76^970^29
+51 ;;^UTILITY(U,$J,358.3,22531,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,22531,1,3,0)
+54 ;;=3^Exposure to/Contact w/ Environmental Tobacco Smoke
+55 ;;^UTILITY(U,$J,358.3,22531,1,4,0)
+56 ;;=4^Z77.22
+57 ;;^UTILITY(U,$J,358.3,22531,2)
+58 ;;=^5063324
+59 ;;^UTILITY(U,$J,358.3,22532,0)
+60 ;;=L30.9^^76^970^5
+61 ;;^UTILITY(U,$J,358.3,22532,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,22532,1,3,0)
+64 ;;=3^Eczema,Unspec
+65 ;;^UTILITY(U,$J,358.3,22532,1,4,0)
+66 ;;=4^L30.9
+67 ;;^UTILITY(U,$J,358.3,22532,2)
+68 ;;=^5009159
+69 ;;^UTILITY(U,$J,358.3,22533,0)
+70 ;;=L23.9^^76^970^2
+71 ;;^UTILITY(U,$J,358.3,22533,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,22533,1,3,0)
+74 ;;=3^Eczema,Allergic Contact,Unspec
+75 ;;^UTILITY(U,$J,358.3,22533,1,4,0)
+76 ;;=4^L23.9
+77 ;;^UTILITY(U,$J,358.3,22533,2)
+78 ;;=^5009125
+79 ;;^UTILITY(U,$J,358.3,22534,0)
+80 ;;=L20.82^^76^970^3
+81 ;;^UTILITY(U,$J,358.3,22534,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,22534,1,3,0)
+84 ;;=3^Eczema,Flexural
+85 ;;^UTILITY(U,$J,358.3,22534,1,4,0)
+86 ;;=4^L20.82
+87 ;;^UTILITY(U,$J,358.3,22534,2)
+88 ;;=^5009109
+89 ;;^UTILITY(U,$J,358.3,22535,0)
+90 ;;=L20.84^^76^970^4
+91 ;;^UTILITY(U,$J,358.3,22535,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,22535,1,3,0)
+94 ;;=3^Eczema,Intrinsic
+95 ;;^UTILITY(U,$J,358.3,22535,1,4,0)
+96 ;;=4^L20.84
+97 ;;^UTILITY(U,$J,358.3,22535,2)
+98 ;;=^5009111
+99 ;;^UTILITY(U,$J,358.3,22536,0)
+100 ;;=L51.8^^76^970^11
+101 ;;^UTILITY(U,$J,358.3,22536,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,22536,1,3,0)
+104 ;;=3^Erythema Multiforme,Other
+105 ;;^UTILITY(U,$J,358.3,22536,1,4,0)
+106 ;;=4^L51.8
+107 ;;^UTILITY(U,$J,358.3,22536,2)
+108 ;;=^336639
+109 ;;^UTILITY(U,$J,358.3,22537,0)
+110 ;;=R23.4^^76^970^15
+111 ;;^UTILITY(U,$J,358.3,22537,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,22537,1,3,0)
+114 ;;=3^Eschar/Desquamination of Skin
+115 ;;^UTILITY(U,$J,358.3,22537,1,4,0)
+116 ;;=4^R23.4
+117 ;;^UTILITY(U,$J,358.3,22537,2)
+118 ;;=^5019296
+119 ;;^UTILITY(U,$J,358.3,22538,0)
+120 ;;=L49.9^^76^970^25
+121 ;;^UTILITY(U,$J,358.3,22538,1,0)
+122 ;;=^358.31IA^4^2
